Resultados da pesquisa - A. Rushing
- A mostrar 1 - 20 resultados de 20
-
1
The Mental Patient Comes Home Por William A. Rushing, Howard E. Freeman, Ozzie G. Simmons
Publicado em 1963Artigo -
2
-
3
-
4
-
5
-
6
-
7
Immediate and Prolonged Patterns of Agouti-Related Peptide-(83–132)-Induced c-Fos Activation in Hypothalamic and Extrahypothalamic Sites* Por Mary M. Hagan, Stephen C. Benoit, Paul A. Rushing, Laurel M. Pritchard, Stephen C. Woods, Randy J. Seeley
Publicado em 2001Artigo -
8
-
9
The Role of CNS Glucagon-Like Peptide-1 (7-36) Amide Receptors in Mediating the Visceral Illness Effects of Lithium Chloride Por Randy J. Seeley, Kathleen Blake, Paul A. Rushing, Stephen C. Benoit, John Eng, Stephen C. Woods, David A. D’Alessio
Publicado em 2000Artigo -
10
-
11
Outcome of selective non-operative management of penetrating abdominal injuries from the North American National Trauma Database Por Syed Nabeel Zafar, A. Rushing, Elliott R. Haut, Mehreen Kisat, Cassandra V. Villegas, Albert Chi, Katherine Stevens, David T. Efron, Hasnain Zafar, A.H. Haider
Publicado em 2011Artigo -
12
A Novel Selective Melanocortin-4 Receptor Agonist Reduces Food Intake in Rats and Mice without Producing Aversive Consequences Por Stephen C. Benoit, Michael W. Schwartz, Jennifer Lachey, Mary M. Hagan, Paul A. Rushing, Kathleen Blake, Keith A. Yagaloff, Grazyna Kurylko, Lucía Franco, Waleed Danhoo, Randy J. Seeley
Publicado em 2000Artigo -
13
Efficacy and safety of trabectedin or dacarbazine in patients with advanced uterine leiomyosarcoma after failure of anthracycline-based chemotherapy: Subgroup analysis of a phase 3... Por Martee L. Hensley, Shreyaskumar Patel, Margaret von Mehren, Kristen N. Ganjoo, Robin L. Jones, Arthur P. Staddon, Daniel A. Rushing, Mohammed Milhem, Bradley J. Monk, George Wang, Sharon McCarthy, R.E. Knoblauch, Trilok Parekh, Robert G. Maki, George D. Demetri
Publicado em 2017Artigo -
14
A phase <scp>II</scp> trial of regorafenib in patients with advanced Ewing sarcoma and related tumors of soft tissue and bone: <scp>SARC024</scp> trial results Por Steven Attia, Vanessa Bolejack, Kristen N. Ganjoo, Suzanne George, Mark Agulnik, Daniel A. Rushing, Elizabeth T. Loggers, Michael B. Livingston, Jennifer Wright, Sant P. Chawla, Scott H. Okuno, Denise K. Reinke, Richard F. Riedel, Lara E. Davis, Christopher W. Ryan, Robert G. Maki
Publicado em 2022Artigo -
15
SARC009: Phase 2 study of dasatinib in patients with previously treated, high‐grade, advanced sarcoma Por Scott M. Schuetze, J. Kyle Wathen, David R. Lucas, Edwin Choy, Brian L. Samuels, Arthur P. Staddon, Kristen N. Ganjoo, Margaret von Mehren, Warren Chow, David M. Loeb, Hussein A. Tawbi, Daniel A. Rushing, Shreyaskumar Patel, Dafydd G. Thomas, Rashmi Chugh, Denise K. Reinke, Laurence H. Baker
Publicado em 2015Artigo -
16
Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma Por Lara E. Davis, Vanessa Bolejack, Christopher W. Ryan, Kristen N. Ganjoo, Elizabeth T. Loggers, Sant P. Chawla, Mark Agulnik, Michael B. Livingston, Damon R. Reed, Vicky L. Keedy, Daniel A. Rushing, Scott H. Okuno, Denise K. Reinke, Richard F. Riedel, Steven Attia, Leo Mascarenhas, Robert G. Maki
Publicado em 2019Artigo -
17
Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor Por Scott M. Schuetze, Vanessa Bolejack, Edwin Choy, Kristen N. Ganjoo, Arthur P. Staddon, Warren Chow, Hussein A. Tawbi, Brian L. Samuels, Shreyaskumar Patel, Margaret von Mehren, Gina Z. D’Amato, Kirsten Leu, David M. Loeb, Charles Forscher, Mohammed Milhem, Daniel A. Rushing, David R. Lucas, Rashmi Chugh, Denise K. Reinke, Laurence H. Baker
Publicado em 2016Artigo -
18
Overall survival and histology‐specific subgroup analyses from a phase 3, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyo... Por Shreyaskumar Patel, Margaret von Mehren, Damon R. Reed, P. Kaiser, John Charlson, Christopher W. Ryan, Daniel A. Rushing, Michael B. Livingston, Arun S. Singh, Rahul Seth, Charles Forscher, Gina Z. D’Amato, Sant P. Chawla, Sharon McCarthy, George Wang, Trilok Parekh, R.E. Knoblauch, Martee L. Hensley, Robert G. Maki, George D. Demetri
Publicado em 2019Artigo -
19
Clinical benefit of a precision medicine based approach for guiding treatment of refractory cancers Por Milan Radovich, Patrick J. Kiel, Stacy Marie Nance, Erin Niland, Megan E. Parsley, Meagan Ferguson, Guanglong Jiang, Natraj Reddy Ammakkanavar, Lawrence H. Einhorn, Liang Cheng, Mehdi Nassiri, Darrell D. Davidson, Daniel A. Rushing, Patrick J. Loehrer, Роберто Пили, N. Hanna, John T. Callaghan, Todd C. Skaar, Paul R. Helft, Safi Shahda, Bert H. O’Neil, Bryan P. Schneider
Publicado em 2016Artigo -
20
SARC006: Phase II Trial of Chemotherapy in Sporadic and Neurofibromatosis Type 1 Associated Chemotherapy-Naive Malignant Peripheral Nerve Sheath Tumors Por Christine S. Higham, Seth M. Steinberg, Eva Dombi, Arie Perry, Lee J. Helman, Scott M. Schuetze, Joseph A. Ludwig, Arthur P. Staddon, Mohammed Milhem, Daniel A. Rushing, Robin L. Jones, Michael B. Livingston, Stewart Goldman, Christopher L. Moertel, Lars M. Wagner, David E. Janhofer, Christina M. Annunziata, Denise K. Reinke, Lauren Long, David Viskochil, Larry Baker, Brigitte C. Widemann
Publicado em 2017Artigo
Ferramentas de pesquisa:
Assuntos relacionados
Medicine
Internal medicine
Oncology
Endocrinology
Surgery
Pathology
Biology
Chemotherapy
Cancer
Receptor
Sarcoma
Soft tissue sarcoma
Body weight
Chemistry
Amylin
Insulin
Islet
Leiomyosarcoma
Melanocortin
Phases of clinical research
Randomized controlled trial
Soft tissue
Solitary tract
Adverse effect
Agonist
Anorectic
Anorexia
Area postrema
Clinical trial
Colorectal cancer